!-- Start Alexa Certify Javascript --> !-- Start Alexa Certify Javascript --> Siliconeer :: A General Interest Magazine for South Asians in U.S.

A General Interest Monthly Magazine for South Asians in the U.S.

Northern California:
SF Bay Area | San Jose | Fremont | Santa Clara
Silicon Valley | Sacramento Area
Southern California: Los Angeles | Artesia | San Diego | Inland Empire

Web siliconeer.com
Advertise in Siliconeer | Home | Subscribe Print Issue | About Us (FAQs) | Contact | Locations | Staff Login | Site Map |





BioPharma in India: U.S.-India Summit

The U.S.-India BioPharma Summit 2008 in Boston attracted over 350 senior bio, pharma, medical devices and healthcare professionals, including participants from 40 leading and emerging BioPharma companies in India. A Siliconeer report.

(Above, left): Karun Rishi. (Right): A section of the audience at the U.S.-India BioPharma Summit

The U.S.-India BioPharma Summit 2008 organized by the USA-India Chamber of Commerce in Boston attracted over 350 senior bio, pharma, medical devices and healthcare professionals, according to a press release from the organizers. Over 40 leading and emerging BioPharma companies from India participated in the summit.

In his opening remarks, Karun Rishi, president of the USA-India Chamber of Commerce, said that innovation and funding innovation will get a big boost from this summit. Collaborative research and strategic alliances will be the key forces deriving the business. He encouraged U.S. companies to expedite and expand their partnerships in India.

Urging the Government of India to improve infrastructure, Rishi said that the sooner India creates world-class roads, airports, buildings, 24x7 water supply and electricity, the faster will be the economic impact not only on the industry but for the common man. He urged the Indian academic institutions to partner with the U.S. BioPharma industry to learn, share, expand capacity and commercialize innovation.

In his keynote address, Indian Minister of Science and Technology Kapil Sibal talked of an emerging intellectual property regime in India that would not only uphold the interests of indulging pharmaceutical companies but shall also match their investment on a 50:50 basis to build an environment to develop collaborative initiatives to mutual benefits in the field of agriculture, marine and health sciences.

Sibal said the challenge was to develop the highest quality drugs at the lowest cost. It is important to devise different business models as current models do not work.

A position paper prepared by McKinsey & Company for the USA-India Chamber of Commerce was officially released by Sibal. Titled “Thought Starters to Spur US-India BioPharma Collaboration,” the report made suggestions to take U.S.-India life sciences and healthcare business to the next level. McKinsey conducted in-depth interviews with senior policy makers, industry leaders and investors to prepare the report.

The U.S.-India Biotech Summit is an annual summit organized by the USA-India Chamber of Commerce which brings together all stakeholders to facilitate the trade and investments in US-India BioPharma and Healthcare industry.

The USA-India Chamber of Commerce is a bilateral chamber of commerce with prime focus on trade, investment, policy and advocacy. For more information, readers can visit www.usaindiachamber.org.


Current Issue in PDF Format:
Click here to read in PDF format

The Obama Revolution:
A New Era in U.S. Politics

The nomination of Sen. Barack Obama for the U.S.presidential elections marks a profound political revolution and South Asians should get on the bandwagon, writes Partha Banerjee.

Ode to a Titan: Faizan-e-Faiz
Urdu enthusiasts gathered to honor the greatest Urdu poet after Ghalib, writes Ras H. Siddiqui.

Our Gods on Earth:
A Rationalist’s Dilemma

When reason gets short shrift in the frenzy over spiritual leaders, what is a rationalist with a scientific temper to do? Sujit Saraf writes about how he chose to write a play.

IIFA Awards 2008
A Siliconeer Exclusive Photo Essay

Honda FCX Clarity:
Next Generation Vehicle

Honda’s next-generation, hydrogen powered fuel cell vehicle’s only emission is water, and its fuel efficiency is three times that of a modern gasoline-powered automobile. A Siliconeer report.

A Trip to Hong Kong: Travels in Cathay

EDITORIAL: Obama and South Asians
SUBCONTINENT: India’s Bio-fuel Option?
COMMUNITY: iForum Meet
COMMUNITY: AAPIO Doctors Celebrate
CONCERT: Indian Ocean Live
BUSINESS: BioPharma in India
AIR TRAVEL: Jet Airways at SFO
MUSIC: An Evening of Ghazals
RECIPE: Makhan Malai Paneer
BOLLYWOOD: Film: Sarkar Raj
TAMIL CINEMA: Pidichirukku
COMMUNITY: News in Brief
COMMUNITY: Gujarat Day

Advertise in Siliconeer | Home | Subscribe PRINT Issue | About Us (FAQs) | Contact | Locations | Staff Login | Site Map
© Copyright 2000-2014 Siliconeer • All Rights Reserved • For Comments and Questions: info (AT) siliconeer.com